Fisher & Paykel Healthcare Corporation Limited (FSPKF)
USD 25.91
(0.0%)
USD 25.91
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 35.7 Million NZD | -54.87% |
| 2023 | 124.5 Million NZD | 42.61% |
| 2022 | 87.3 Million NZD | -4.9% |
| 2021 | 91.8 Million NZD | 108.64% |
| 2020 | 44 Million NZD | -36.23% |
| 2019 | 69 Million AUD | 31.43% |
| 2018 | 52.5 Million AUD | 31.41% |
| 2017 | 39.95 Million AUD | -14.73% |
| 2016 | 46.85 Million AUD | -8.74% |
| 2015 | 51.34 Million AUD | -19.24% |
| 2014 | 63.57 Million AUD | -45.85% |
| 2013 | 117.38 Million AUD | 240.15% |
| 2012 | 34.51 Million AUD | -57.88% |
| 2011 | 81.93 Million AUD | 37.46% |
| 2010 | 59.61 Million AUD | -38.87% |
| 2009 | 97.51 Million AUD | 361.98% |
| 2008 | 21.1 Million AUD | 0.0% |
| 2007 | - AUD | 0.0% |
| 2006 | - AUD | 0.0% |
| 2005 | - AUD | -100.0% |
| 2004 | 1.85 Million AUD | 0.0% |
| 2003 | - AUD | -100.0% |
| 2002 | 1.52 Million AUD | -10.75% |
| 2001 | 1.7 Million AUD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 FY | 35.7 Million NZD | -71.33% |
| 2024 Q4 | 35.7 Million NZD | 0.0% |
| 2024 Q2 | 237.3 Million NZD | 1.18% |
| 2024 Q1 | 276.09 Million NZD | 176.47% |
| 2023 Q4 | 124.5 Million NZD | 7.21% |
| 2023 FY | 124.5 Million NZD | 42.61% |
| 2023 Q1 | 99.86 Million NZD | 14.39% |
| 2023 Q2 | 70 Million NZD | -29.91% |
| 2023 Q3 | 116.12 Million NZD | 65.9% |
| 2022 Q4 | 87.3 Million NZD | 0.0% |
| 2022 FY | 87.3 Million NZD | -4.9% |
| 2021 Q4 | 91.8 Million NZD | 0.0% |
| 2021 FY | 91.8 Million NZD | 108.64% |
| 2020 Q4 | 44 Million NZD | 0.0% |
| 2020 FY | 44 Million NZD | -36.23% |
| 2019 Q4 | 69 Million AUD | 0.0% |
| 2019 FY | 69 Million AUD | 31.43% |
| 2018 FY | 52.5 Million AUD | 31.41% |
| 2018 Q4 | 52.5 Million AUD | 0.0% |
| 2017 Q4 | 39.95 Million AUD | 0.0% |
| 2017 FY | 39.95 Million AUD | -14.73% |
| 2016 FY | 46.85 Million AUD | -8.74% |
| 2016 Q4 | 46.85 Million AUD | 0.0% |
| 2015 FY | 51.34 Million AUD | -19.24% |
| 2015 Q4 | 51.34 Million AUD | 0.0% |
| 2014 Q4 | 63.57 Million AUD | 0.0% |
| 2014 FY | 63.57 Million AUD | -45.85% |
| 2013 FY | 117.38 Million AUD | 240.15% |
| 2013 Q4 | 117.38 Million AUD | 0.0% |
| 2012 Q4 | 34.51 Million AUD | 0.0% |
| 2012 FY | 34.51 Million AUD | -57.88% |
| 2011 Q4 | 81.93 Million AUD | 0.0% |
| 2011 FY | 81.93 Million AUD | 37.46% |
| 2010 Q4 | 59.61 Million AUD | 0.0% |
| 2010 FY | 59.61 Million AUD | -38.87% |
| 2009 FY | 97.51 Million AUD | 361.98% |
| 2009 Q4 | 97.51 Million AUD | 0.0% |
| 2008 FY | 21.1 Million AUD | 0.0% |
| 2008 Q4 | 21.1 Million AUD | 0.0% |
| 2007 Q4 | - AUD | 0.0% |
| 2007 FY | - AUD | 0.0% |
| 2006 FY | - AUD | 0.0% |
| 2006 Q4 | - AUD | 0.0% |
| 2005 FY | - AUD | -100.0% |
| 2005 Q4 | - AUD | 0.0% |
| 2004 Q4 | 1.85 Million AUD | 0.0% |
| 2004 FY | 1.85 Million AUD | 0.0% |
| 2003 Q4 | - AUD | 0.0% |
| 2003 FY | - AUD | -100.0% |
| 2002 FY | 1.52 Million AUD | -10.75% |
| 2001 FY | 1.7 Million AUD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | - USD | -Infinity% |
| Ansell Limited | 705.27 Million USD | 94.938% |
| Ansell Limited | 706.6 Million USD | 94.948% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | -59.293% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | - USD | -Infinity% |
| Psykey, Inc. | 625 Thousand USD | -5612.0% |
| ConvaTec Group Plc | 1.22 Billion USD | 97.086% |
| ConvaTec Group Plc | 1.22 Billion USD | 97.09% |
| Encision Inc. | 67.33 Thousand USD | -52917.702% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 382.83 Thousand USD | -9225.117% |
| LifePoint, Inc. | 151.73 Thousand USD | -23428.016% |
| Medite Cancer Diagnostics, Inc. | 4.91 Million USD | -626.496% |
| Paradigm Medical Industries, Inc. | 615 Thousand USD | -5704.878% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 179.96 Thousand USD | -19737.411% |
| SmileDirectClub, Inc. | 849.37 Million USD | 95.797% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 210.77 Million USD | 83.063% |
| SheerVision, Inc. | - USD | -Infinity% |
| United Health Products, Inc. | 48.48 Thousand USD | -73524.946% |
| Vasamed, Inc. | 18.95 Thousand USD | -188290.501% |
| Wearable Health Solutions, Inc. | 18.46 Thousand USD | -193207.342% |
| Yubo International Biotech Limited | 390.44 Thousand USD | -9043.413% |